Skip to Content

5,660 Results Found

  • Article
  • Open Access
10 Citations
4,026 Views
17 Pages

A Novel Real Coded Genetic Algorithm for Software Mutation Testing

  • Deepti Bala Mishra,
  • Biswaranjan Acharya,
  • Dharashree Rath,
  • Vassilis C. Gerogiannis and
  • Andreas Kanavos

26 July 2022

Information Technology has rapidly developed in recent years and software systems can play a critical role in the symmetry of the technology. Regarding the field of software testing, white-box unit-level testing constitutes the backbone of all other...

(This article belongs to the Special Issue Recent Advances in Software for Symmetry)
  • Proceeding Paper
  • Open Access
2,305 Views
4 Pages

In this article, we propose the definition of specific mutation operators for testing Geographic Information Systems. We describe the process for applying the operators and generating mutants, and present a case study where these mutation operators a...

(This article belongs to the Proceedings of The 2nd XoveTIC Conference (XoveTIC 2019))
  • Article
  • Open Access
1 Citations
2,523 Views
13 Pages

11 August 2023

Data-Flow and Higher-Order Mutation are white-box testing techniques. To our knowledge, no work has been proposed to compare data flow and Higher-Order Mutation. This paper compares all def-uses Data-Flow and second-order mutation criteria. The compa...

(This article belongs to the Topic Software Engineering and Applications)
  • Article
  • Open Access
14 Citations
4,726 Views
14 Pages

Automatic Classification of Equivalent Mutants in Mutation Testing of Android Applications

  • Muhammad Bello Kusharki,
  • Sanjay Misra,
  • Bilkisu Muhammad-Bello,
  • Ibrahim Anka Salihu and
  • Bharti Suri

14 April 2022

Software and symmetric testing methodologies are primarily used in detecting software defects, but these testing methodologies need to be optimized to mitigate the wasting of resources. As mobile applications are becoming more prevalent in recent tim...

(This article belongs to the Special Issue Recent Advances in Software for Symmetry)
  • Article
  • Open Access
1 Citations
3,016 Views
22 Pages

Testing an intricate plexus of advanced software system architecture is quite challenging due to the absence of test oracle. Metamorphic testing is a popular technique to alleviate the test oracle problem. The effectiveness of metamorphic testing is...

  • Article
  • Open Access
34 Citations
6,330 Views
26 Pages

9 September 2019

Manual test case generation is an exhaustive and time-consuming process. However, automated test data generation may reduce the efforts and assist in creating an adequate test suite embracing predefined goals. The quality of a test suite depends on i...

  • Article
  • Open Access
821 Views
40 Pages

23 December 2025

Fault concealment in complex software programs and the difficulty of generating test cases to detect such faults present significant challenges in software testing. To resolve these challenges, this paper suggests a novel method that integrates mutat...

  • Article
  • Open Access
17 Citations
6,792 Views
26 Pages

Deep Learning for Hyperspectral Image Classification: A Critical Evaluation via Mutation Testing

  • Zhifei Chen,
  • Yang Hao,
  • Qichao Liu,
  • Yuyong Liu and ,
  • Mingyang Zhu and
  • Liang Xiao
  • + 1 author+ 0 author

16 December 2024

Recently, there has been a surge in the adoption of deep learning (DL) techniques, especially convolutional neural networks (CNNs), to perform hyperspectral image (HSI) classification. Although deep learners have been shown to achieve impressive perf...

  • Article
  • Open Access
10 Citations
2,698 Views
23 Pages

8 November 2022

In this work, we propose a new test case generation approach that can cover behavioural scenarios individually in a multi-agent system. The purpose is to identify, in the case of the detection of an error, the scenario that caused the detected error,...

(This article belongs to the Section Computer Science & Engineering)
  • Article
  • Open Access
14 Citations
5,174 Views
15 Pages

Cancer gene panel testing requires accurate detection of somatic mosaic mutations, as the test sample consists of a mixture of cancer cells and normal cells; each minor clone in the tumor also has different somatic mutations. Several studies have sho...

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
  • Article
  • Open Access
352 Views
26 Pages

27 September 2026

Assurance for autonomous agents depends on operational evidence about policy decisions, actions, execution, effects, provenance, and enforcement. This study tests whether bounded assurance claims remain semantically admissible when that evidence is a...

  • Article
  • Open Access
27 Citations
3,922 Views
11 Pages

31 May 2022

To overcome the limitations of the tissue biopsy and plasma cfDNA liquid biopsy, we performed the EV-based BALF liquid biopsy of 224 newly diagnosed stage III-IV NSCLC patients and compared it with tissue genotyping and 110 plasma liquid biopsies. Is...

(This article belongs to the Special Issue Liquid Biopsy: Current Status and Future Perspectives)
  • Article
  • Open Access
15 Citations
4,063 Views
12 Pages

Reliability of Tumor Testing Compared to Germline Testing for Detecting BRCA1 and BRCA2 Mutations in Patients with Epithelial Ovarian Cancer

  • Christine Bekos,
  • Christoph Grimm,
  • Marlene Kranawetter,
  • Stephan Polterauer and ,
  • Felicitas Oberndorfer,
  • Yen Tan,
  • Leonhard Müllauer and
  • Christian F. Singer
  • + 3 authors+ 0 author

24 June 2021

Background: BRCA 1/2 mutation status has become one of the most important parameters for treatment decision in patients with epithelial ovarian cancer (EOC). The aim of this study was to compare tumor DNA with blood DNA sequencing to evaluate the rel...

(This article belongs to the Special Issue Molecular Pathology of Cancer: The Past, the Present, and the Future)
  • Article
  • Open Access
2 Citations
3,434 Views
11 Pages

29 November 2023

Aims: This study aims to investigate the potential influence of melanin content on the performance of the Idylla™ BRAF Mutation Test. Specifically, we assess whether melanin levels in samples impact the test’s reliability, thereby validat...

  • Review
  • Open Access
12 Citations
5,899 Views
18 Pages

Defining the Criteria for Reflex Testing for BRAF Mutations in Cutaneous Melanoma Patients

  • Sarah Zhou,
  • Daniel Sikorski,
  • Honghao Xu,
  • Andrei Zubarev and ,
  • May Chergui,
  • François Lagacé,
  • Wilson H. Miller,
  • Margaret Redpath,
  • Stephanie Ghazal and
  • Ivan V. Litvinov
  • + 11 authors+ 6 authors

10 May 2021

Targeted therapy has been developed through an in-depth understanding of molecular pathways involved in the pathogenesis of melanoma. Approximately ~50% of patients with melanoma have tumors that harbor a mutation of the BRAF oncogene. Certain clinic...

(This article belongs to the Special Issue Systemic Therapies in Melanoma)
  • Article
  • Open Access
8 Citations
4,565 Views
24 Pages

23 August 2019

Fault localization techniques reduce the effort required when debugging software, as revealed by previous test cases. However, many test cases are required to reduce the number of candidate fault locations. To overcome this disadvantage, various meth...

(This article belongs to the Section Computing and Artificial Intelligence)
  • Review
  • Open Access
37 Citations
8,351 Views
16 Pages

10 October 2021

The administration of many cancer drugs is tailored to genetic tests. Some genomic events, e.g., alterations of EGFR or BRAF oncogenes, result in the conformational change of the corresponding proteins and call for the use of mutation-specific compou...

(This article belongs to the Special Issue Quo Vadis Cancer Research? On Molecular Mechanisms and Drug Discovery)
  • Review
  • Open Access
18 Citations
7,355 Views
19 Pages

Exercise Testing, Physical Training and Fatigue in Patients with Mitochondrial Myopathy Related to mtDNA Mutations

  • Tina D. Jeppesen,
  • Karen L. Madsen,
  • Nanna S. Poulsen,
  • Nicoline Løkken and
  • John Vissing

20 April 2021

Mutations in mitochondrial DNA (mtDNA) cause disruption of the oxidative phosphorylation chain and impair energy production in cells throughout the human body. Primary mitochondrial disorders due to mtDNA mutations can present with symptoms from adul...

(This article belongs to the Special Issue Mitochondrial Disorders: Molecular, Clinical and Therapeutic Advances)
  • Article
  • Open Access
2 Citations
4,450 Views
18 Pages

19 February 2020

Nowadays, embedded systems are increasingly complex, meaning that traditional testing methods are costly to use and infeasible to directly apply due to the complex interactions between hardware and software. Modern embedded systems are also demanded...

(This article belongs to the Special Issue Challenges and Directions Forward for Dealing with the Complexity of Future Smart Cyber–Physical Systems)
  • Guidelines
  • Open Access
12 Citations
7,363 Views
27 Pages

The Clinical Utility of FLT3 Mutation Testing in Acute Leukemia: A Canadian Consensus

  • Julie Bergeron,
  • Jose-Mario Capo-Chichi,
  • Hubert Tsui,
  • Etienne Mahe and ,
  • Philip Berardi,
  • Mark D. Minden,
  • Joseph M. Brandwein and
  • Andre C. Schuh
  • + 3 authors+ 0 author

12 December 2023

FMS-like tyrosine kinase 3 (FLT3) mutations are detected in approximately 20–30% of patients with acute myeloid leukemia (AML), with the presence of a FLT3 internal tandem duplication (FLT3-ITD) mutation being associated with an inferior outcom...

  • Article
  • Open Access
2,297 Views
11 Pages

Epidermal Growth Factor Receptor (EGFR) Amplification May Lead to Invalid Cobas EGFR Mutation Test v2 Results

  • Min-Shu Hsieh,
  • Tze-Chun Hung,
  • Hsien-Neng Huang,
  • Chao-Wen Lu and ,
  • Hsiang-Wei Hu,
  • Jin-Yao Lai,
  • Wen-Yao Lee and
  • Jin-Shing Chen
  • + 3 authors+ 0 author

Background/Objectives: The cobas EGFR test v2, used for detecting EGFR mutations, can yield invalid results due to internal control (IC) issues, such as “IC not detected”, “IC out of range: high Ct value”, or “IC out of...

(This article belongs to the Section Pathology and Molecular Diagnostics)
  • Article
  • Open Access
12 Citations
3,552 Views
9 Pages

The Use of ctDNA for BRAF Mutation Testing in Routine Clinical Practice in Patients with Advanced Melanoma

  • Paweł Sobczuk,
  • Katarzyna Kozak,
  • Sylwia Kopeć,
  • Paweł Rogala and ,
  • Tomasz Świtaj,
  • Hanna Koseła-Paterczyk,
  • Aleksandra Gos,
  • Andrzej Tysarowski and
  • Piotr Rutkowski
  • + 4 authors+ 0 author

2 February 2022

Assessment of BRAF mutation status is mandatory in advanced, treatment-naïve melanoma patients. Liquid biopsy can be an alternative in cases with inadequate or unavailable tumor tissue. The aim of our study was to evaluate the clinical utility o...

(This article belongs to the Special Issue Biomarkers in Melanoma Patients)
  • Article
  • Open Access
5 Citations
3,370 Views
10 Pages

Combined Tumor-Based BRCA1/2 and TP53 Mutation Testing in Ovarian Cancer

  • Edith Borcoman,
  • Elizabeth Santana dos Santos,
  • Catherine Genestie,
  • Patricia Pautier and ,
  • Ludovic Lacroix,
  • Sandrine M. Caputo,
  • Odile Cabaret,
  • Marine Guillaud-Bataille,
  • Judith Michels and
  • Etienne Rouleau
  • + 7 authors+ 2 authors

Somatic/germline BRCA1/2 mutations (m)/(likely) pathogenic variants (PV) (s/gBRCAm) remain the best predictive biomarker for PARP inhibitor efficacy. As >95% of high-grade serous ovarian cancers (HGSOC) have a somatic TP53m, combined tumor-based B...

(This article belongs to the Special Issue Advances in Gynecological Cancers 2.0)
  • Article
  • Open Access
19 Citations
4,498 Views
16 Pages

Tumor BRCA Testing in High Grade Serous Carcinoma: Mutation Rates and Optimal Tissue Requirements

  • Gulisa Turashvili,
  • Conxi Lazaro,
  • Shengjie Ying,
  • George Charames and ,
  • Andrew Wong,
  • Krista Hamilton,
  • Denise Yee,
  • Evangeline Agro,
  • Martin Chang and
  • Jordan Lerner-Ellis
  • + 6 authors+ 1 author

21 November 2020

Background: Approximately 25% of women diagnosed with tubo-ovarian high-grade serous carcinoma have germline deleterious mutations in BRCA1 or BRCA2, characteristic of hereditary breast and ovarian cancer syndrome, while somatic mutations have been d...

(This article belongs to the Special Issue Changing Landscape of Hereditary Breast and Ovarian Cancer)
  • Article
  • Open Access
22 Citations
7,026 Views
27 Pages

A Nationwide Study on the Impact of Routine Testing for EGFR Mutations in Advanced NSCLC Reveals Distinct Survival Patterns Based on EGFR Mutation Subclasses

  • Bart Koopman,
  • Betzabel N. Cajiao Garcia,
  • Chantal C. H. J. Kuijpers,
  • Ronald A. M. Damhuis and ,
  • Anthonie J. van der Wekken,
  • Harry J. M. Groen,
  • Ed Schuuring,
  • Stefan M. Willems and
  • Léon C. van Kempen
  • + 4 authors+ 0 author

20 July 2021

EGFR mutation analysis in non-small-cell lung cancer (NSCLC) patients is currently standard-of-care. We determined the uptake of EGFR testing, test results and survival of EGFR-mutant NSCLC patients in the Netherlands, with the overall objective to c...

(This article belongs to the Section Cancer Therapy)
  • Article
  • Open Access
28 Citations
1,696 Views
7 Pages

Rate of Egfr Mutation Testing for Patients with Nonsquamous Non-Small-Cell Lung Cancer with Implementation of Reflex Testing by Pathologists

  • P.K. Cheema,
  • S. Raphael,
  • R. El-Maraghi,
  • J. Li and ,
  • R. McClure,
  • L. Zibdawi,
  • A. Chan,
  • J.C. Victor,
  • A. Dolley and
  • A. Dziarmaga
  • + 5 authors+ 0 author

1 February 2017

Background: Testing for mutation of the EGFR (epidermal growth factor receptor) gene is a standard of care for patients with advanced nonsquamous non-small-cell lung cancer (nsclc). To improve timely access to EGFR results, a few centres implemented...

  • Article
  • Open Access
4 Citations
3,512 Views
11 Pages

13 December 2021

Dystrophic epidermolysis bullosa (DEB) is an inheritable blistering disease caused by mutations in COL7A1, which encodes type VII collagen. To address the issue of genotype-phenotype correlations in DEB, analyzing the consequences of COL7A1 mutations...

(This article belongs to the Special Issue Molecular Advances in Skin Diseases)
  • Article
  • Open Access
1 Citations
2,967 Views
18 Pages

cfDNA Chimerism and Somatic Mutation Testing in Early Prediction of Relapse After Allogeneic Stem Cell Transplantation for Myeloid Malignancies

  • Scott D. Rowley,
  • Maher Albitar,
  • Melissa F. Baker,
  • Alaa Ali and ,
  • Sukhdeep Kaur,
  • Hyung C. Suh,
  • Andre Goy and
  • Michele L. Donato
  • + 3 authors+ 0 author

13 February 2025

Background: Disease relapse is a primary cause of treatment failure after hematopoietic stem cell transplantation in the treatment of malignancy. Consolidation therapy early after transplantation may reduce this risk, but it is difficult to administe...

(This article belongs to the Section Transplant Oncology)
  • Brief Report
  • Open Access
1 Citations
3,371 Views
9 Pages

ERBB2 Mutation Testing in NSCLC: A Pan-European Real-World Evaluation of the Oncomine Precision Assay

  • Ilaria Alborelli,
  • Melanie Demes,
  • Peter Wild,
  • Susana Hernandez and ,
  • Fernando Lopez-Rios,
  • Olivier Bordone,
  • Christophe Bontoux,
  • Paul Hofman,
  • Caterina De Luca and
  • Lukas Bubendorf
  • + 14 authors+ 9 authors

Background/Objectives: The non-small-cell lung cancer (NSCLC) therapeutic landscape has undergone a profound transformation with the introduction of multiple personalized treatment options. Mutations in ERBB2 (HER2) have recently emerged as promising...

  • Article
  • Open Access
8 Citations
3,447 Views
14 Pages

7 July 2023

Background: The detection of the EGFR T790M (T790M) mutation in non-small cell lung cancer (NSCLC) patients who progressed under treatment with first- or second-generation EGFR-tyrosine kinase inhibitors (TKIs) is important to offer a subsequent ther...

(This article belongs to the Section Cancer Metastasis)
  • Article
  • Open Access
6 Citations
3,078 Views
19 Pages

7 February 2021

Specification-based testing methods generate test data without the knowledge of the structure of the program. However, the quality of these test data are not well ensured to detect bugs when non-functional changes are introduced to the program. To ge...

(This article belongs to the Special Issue Mathematics in Software Reliability and Quality Assurance)
  • Article
  • Open Access
2 Citations
1,176 Views
11 Pages

Clinical Benefits of KRAS/GNAS Gene Mutation Analysis in Addition to Morphology and Conventional Cyst Fluid Testing in Differentiating Pancreatic Cysts

  • György Gyimesi,
  • Bánk Keczer,
  • Péter Rein,
  • Miklós Horváth and ,
  • Bálint Gellért,
  • Tamás Marjai,
  • Enikő Tóth,
  • Ákos Szűcs,
  • Attila Szijártó and
  • István Hritz
  • + 7 authors+ 2 authors

7 December 2025

Objectives: Pancreatic cystic lesions (PCLs) are increasingly detected due to the widespread use of imaging techniques. The identification of pancreatic mucinous cysts is especially important since these carry a risk of malignant transformation and r...

(This article belongs to the Special Issue Endoscopic Diagnosis and Treatments of Gastrointestinal Diseases)
  • Article
  • Open Access
5 Citations
3,457 Views
39 Pages

A Model for Predicting Statement Mutation Scores

  • Lili Tan,
  • Yunzhan Gong and
  • Yawen Wang

23 August 2019

A test suite plays a key role in software testing. Mutation testing is a powerful approach to measure the fault-detection ability of a test suite. The mutation testing process requires a large number of mutants to be generated and executed. Hence, mu...

(This article belongs to the Special Issue Applied and Computational Statistics)
  • Article
  • Open Access
4 Citations
3,585 Views
24 Pages

GaSubtle: A New Genetic Algorithm for Generating Subtle Higher-Order Mutants

  • Fadi Wedyan,
  • Abdullah Al-Shishani and
  • Yaser Jararweh

Mutation testing is an effective, yet costly, testing approach, as it requires generating and running large numbers of faulty programs, called mutants. Mutation testing also suffers from a fundamental problem, which is having a large percentage of eq...

(This article belongs to the Special Issue Information for Business and Management–Software Development for Data Processing and Management)
  • Article
  • Open Access
23 Citations
1,334 Views
5 Pages

Canadian Expert Group Consensus Recommendations: KRAS Testing in Colorectal Cancer

  • F. Aubin,
  • S. Gill,
  • R. Burkes,
  • B. Colwell and ,
  • S. Kamel–Reid,
  • S. Koski,
  • A. Pollett,
  • B. Samson,
  • M. Tehfe and
  • D. Soulières
  • + 7 authors+ 2 authors

1 August 2011

Monoclonal antibodies against the epidermal growth factor receptor (anti-egfr) when used in the treatment of metastatic colorectal cancer are associated with improved survival. Patients whose tumours harbor a KRAS mutation in codon 12 or 13 have been...

  • Article
  • Open Access
11 Citations
3,730 Views
23 Pages

26 October 2020

Many test case prioritization (TCP) studies based on regression testing using a code-based development approach have appeared. However, few studies on model-based mutation testing have explored what kind of fault seeding is appropriate or how much th...

(This article belongs to the Section Computing and Artificial Intelligence)
  • Article
  • Open Access
9 Citations
5,527 Views
17 Pages

Adaptive Mutation Dynamic Search Fireworks Algorithm

  • Xi-Guang Li,
  • Shou-Fei Han,
  • Liang Zhao,
  • Chang-Qing Gong and
  • Xiao-Jing Liu

28 April 2017

The Dynamic Search Fireworks Algorithm (dynFWA) is an effective algorithm for solving optimization problems. However, dynFWA easily falls into local optimal solutions prematurely and it also has a slow convergence rate. In order to improve these prob...

  • Article
  • Open Access
1 Citations
2,196 Views
12 Pages

High RAS Allele Frequency Signals Increased Risk of TERT Promoter Mutations in Thyroid Tumors

  • Coralie Lefebvre,
  • Hannah Greenspoon,
  • Kayla E. Payne,
  • Emily Steinberg and ,
  • Felicia Tewfik,
  • Gianluca Savoia,
  • Sabrina Daniela da Silva,
  • Marc Pusztaszeri,
  • Véronique-Isabelle Forest and
  • Richard J. Payne
  • + 5 authors+ 0 author

30 August 2025

Background/Objectives: RAS mutations are among the most common genetic alterations in thyroid cancer and are generally associated with less aggressive behavior. However, when co-occurring with TERT (telomerase reverse transcriptase) promoter mutation...

(This article belongs to the Section Molecular Cancer Biology)
  • Article
  • Open Access
4 Citations
4,612 Views
11 Pages

6 May 2023

Background: The National Comprehensive Cancer Network (NCCN) testing criteria for the high-penetrance breast cancer susceptibility genes, specifically BRCA1, BRCA2, CDH1, PALB2, PTEN, and TP53, have been recently modified in 2023 to 2023 v.1. The fol...

  • Case Report
  • Open Access
8 Citations
3,497 Views
8 Pages

Identification of a Novel de Novo Variant in the SYT2 Gene Causing a Rare Type of Distal Hereditary Motor Neuropathy

  • Olga Mironovich,
  • Elena Dadali,
  • Sergey Malmberg,
  • Tatyana Markova and ,
  • Oxana Ryzhkova and
  • Aleksander Poliakov
  • + 1 author+ 0 author

22 October 2020

Objective: To report the first de novo missense mutation in the SYT2 gene causing distal hereditary motor neuropathy. Methods: Genetic testing was carried out, including clinical exome sequencing for the proband and Sanger sequencing for the proband...

(This article belongs to the Special Issue Genetic Basis of Sensory and Neurological Disorders)
  • Article
  • Open Access

18 November 2026

Mutation testing is a powerful technique for ensuring software quality. However, the presence of the equivalent mutant’s problem is one of the crucial problems in mutation testing. In consequence of its existence, the effectiveness of mutation...

  • Article
  • Open Access
662 Views
29 Pages

10 July 2026

Safety-critical cyber-physical systems require strict verification methodologies explicitly taken to reference safety properties in their tests. Conventional methods of mutation testing simply lump all mutants together, regardless of their effects on...

(This article belongs to the Section Computing and Artificial Intelligence)
  • Article
  • Open Access
9 Citations
2,866 Views
16 Pages

Tradescantia-Based Test Systems Can Be Used for the Evaluation of the Toxic Potential of Harmful Algal Blooms

  • Alla Khosrovyan,
  • Rima Avalyan,
  • Anahit Atoyants,
  • Evelina Aghajanyan and ,
  • Lusine Hambaryan,
  • Rouben Aroutiounian and
  • Bardukh Gabrielyan
  • + 2 authors+ 0 author

7 July 2023

Harmful algal blooms (HABs) are overgrowths of toxic strains of algae (diatoms, green) and cyanobacteria (blue-green algae). While occurring naturally, human-induced environmental changes have resulted in more frequent occurrences of such blooms worl...

(This article belongs to the Special Issue Biodiversity and Ecosystem Services in Rivers)
  • Article
  • Open Access
3 Citations
4,390 Views
14 Pages

BRCA1/2 Mutation Testing in Patients with HER2-Negative Advanced Breast Cancer: Real-World Data from the United States, Europe, and Israel

  • Reshma Mahtani,
  • Alexander Niyazov,
  • Bhakti Arondekar,
  • Katie Lewis and ,
  • Alex Rider,
  • Lucy Massey and
  • Michael Patrick Lux
  • + 2 authors+ 0 author

2 November 2022

Poly(adenosine diphosphate-ribose) polymerase inhibitors are approved to treat patients harboring a germline breast cancer susceptibility gene 1 or 2 mutation (BRCA1/2mut) with human epidermal growth factor receptor 2—negative (HER2−) adv...

(This article belongs to the Collection Breast Cancer—Therapeutic Challenges, Research Strategies and Novel Diagnostics)
  • Article
  • Open Access
69 Views
30 Pages

AdapFuzz: Adaptive Seed Generation for Fuzzers

  • Xiajing Wang,
  • Lifeng Gu and
  • Xueping Wang

17 November 2026

Fuzzing is a widely adopted software testing technique in software engineering for discovering bugs and security vulnerabilities. However, even state-of-the-art mutation-based or generation-based fuzzers fail to provide efficient and scalable solutio...

(This article belongs to the Section Computing and Artificial Intelligence)
  • Article
  • Open Access
1 Citations
2,807 Views
12 Pages

22 May 2020

The first problem considered in this paper is the problem of correctness of a mutation model used in the DNA VIEW program. To this end, we theoretically predict population allele frequency changes in time according to this and similar models (we dete...

(This article belongs to the Section Applied Biosciences and Bioengineering)
  • Article
  • Open Access
12 Citations
3,351 Views
11 Pages

Prognostic Indicators of EIF1AX-Mutated Thyroid Tumor Malignancy and Cancer Aggressiveness

  • Saruchi Bandargal,
  • Tanya Chen,
  • Marc Philippe Pusztaszeri,
  • Véronique-Isabelle Forest and ,
  • Sabrina Daniela da Silva and
  • Richard J. Payne
  • + 1 author+ 0 author

11 December 2022

The risk of malignancy (ROM) of EIF1AX-mutated thyroid nodules has been theorized to be contingent on the position of the mutation within the gene and the presence of co-existing mutations. However, due to EIF1AX’s low mutation frequency, sampl...

(This article belongs to the Special Issue The Molecular Basis of Thyroid Cancer)
  • Article
  • Open Access
1 Citations
3,285 Views
14 Pages

Moving towards a Mutant-Based Testing Tool for Verifying Behavior Maintenance in Test Code Refactorings

  • Tiago Samuel Rodrigues Teixeira,
  • Fábio Fagundes Silveira and
  • Eduardo Martins Guerra

13 November 2023

Evaluating mutation testing behavior can help decide whether refactoring successfully maintains the expected initial test results. Moreover, manually performing this analytical work is both time-consuming and prone to errors. This paper extends an ap...

(This article belongs to the Special Issue Selected Papers from the 23rd International Conference on Computational Science and Its Applications (ICCSA 2023))
  • Article
  • Open Access
10 Citations
3,557 Views
20 Pages

The Toxicological Assessment of Anoectochilus burmannicus Ethanolic-Extract-Synthesized Selenium Nanoparticles Using Cell Culture, Bacteria, and Drosophila melanogaster as Suitable Models

  • Pensiri Buacheen,
  • Jirarat Karinchai,
  • Woorawee Inthachat,
  • Chutikarn Butkinaree and ,
  • Chonchawan Jankam,
  • Ariyaphong Wongnoppavich,
  • Arisa Imsumran,
  • Teera Chewonarin,
  • Nuttaporn Pimpha and
  • Pornsiri Pitchakarn
  • + 6 authors+ 1 author

22 October 2023

Selenium nanoparticles (SeNPs) are worthy of attention and development for nutritional supplementation due to their health benefits in both animals and humans with low toxicity, improved bioavailability, and controlled release, being greater than the...

(This article belongs to the Special Issue Advances in Toxicity of Nanoparticles in Organisms)
  • Article
  • Open Access
17 Citations
4,373 Views
11 Pages

Effect of Having Concurrent Mutations on the Degree of Aggressiveness in Patients with Thyroid Cancer Positive for TERT Promoter Mutations

  • Sama Alohali,
  • Alexandra E. Payne,
  • Marc Pusztaszeri,
  • Mohannad Rajab and ,
  • Véronique-Isabelle Forest,
  • Michael P. Hier,
  • Michael Tamilia and
  • Richard J. Payne
  • + 3 authors+ 0 author

8 January 2023

This study aimed to examine whether concurrent mutations with a TERT promoter mutation are associated with a greater likelihood of more aggressive disease than a TERT promoter mutation alone. The medical records of 1477 patients who underwent thyroid...

(This article belongs to the Special Issue Molecular Testing for Thyroid Nodules and Cancer)

of 114